Our findings show that downregulation of TRβ induced by SPP1 administration aggravated PA-induced lipid deposition in the liver, which was rescued by TRβ overexpression, indicating that SPP1-TRβ is involved in the pathological processes of NAFLD. This evidence concerns the gene SPP1 and metabolic dysfunction-associated steatotic liver disease.